OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY Palak J. Trivedi; Cynthia Levy; Kris V. Kowdley; Stuart C. Gordon; Christopher L. Bowlus; Maria Carlota Londoño Hurtado; Gideon M. Hirschfield; Aliya F. Gulamhusien; Eric J. Lawitz; Alejandra Villamil; Alma Ladron de Guevara Cetina; Marlyn J. Mayo; Ziad H. Younes; Oren Shibolet; Kidist K. Yimam; Daniel S. Pratt; Jeong Heo; Ulrike Morgera; Pietro Andreone; Andreas E. Kremer; Christophe Corpechot; Aparna Goel; Adam Peyton; Hany Elbeshbeshy; Daria B. Crittenden; Carrie Heusner; Sarah Proehl; Shuqiong Zhou; Charles A. McWherter;

Pruritus in primary biliary cholangitis: insights from the German PBC registry across secondary and tertiary care Toni Herta; Annegret Franke; Tobias Müller; Kerstin Stein; Heike Bantel; Rainer Günther; Gerald Denk; Philipp A. Reuken; Jörn M. Schattenberg; Uwe Naumann; Tobias Böttler; Andreas Weber; Stefan Zeuzem; Matthias Hinz; Robin Greinert; Christoph Berg; Thaddäus Till Wissniowski; Karl-Georg Simon; Jonel Trebicka; Rüdiger Behrens; Harald Grümmer; Wolf Peter Hofmann; Nektarios Dikopoulos; Christoph Sarrazin; Elke Roeb; Marion Muche; Marc Ringelhan; Andreas Teufel; Uta Merle; Verena Keitel; Jens U. Marquardt; Achim Kautz; Frank Tacke; Katja Piotrowski; Nicole Köppe-Bauernfeind; Christian Trautwein; Thomas Berg; Johannes Wiegand; Andreas E. Kremer;

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED CIRRHOSIS IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE TRIAL Alejandra M. Villamil; Ziad Younes; Christopher L. Bowlus; John M. Vierling; Adam Vasura; Andrea Galli; Mordechai Rabinovitz; Frederik Nevens; Susheela Carroll; Ke Yang; Daria B. Crittenden; Charles A. McWherter; Eric J. Lawitz;